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https://doi.org/10.1111/mcn.12503Abstract
We evaluated effects of antiretroviral (ARV) therapy and lipid‐based nutrient supplements (LNSs)
on iron, copper, and zinc in milk of exclusively breastfeeding HIV‐infected Malawian mothers and
their correlations with maternal and infant biomarkers. Human milk and blood at 2, 6, and
24 weeks post‐partum and blood during pregnancy (≤30 weeks gestation) were collected from
535 mothers/infant‐pairs in the Breastfeeding, Antiretrovirals, and Nutrition study. The partici-
pants received ARV, LNS, ARV and LNS, or no intervention from 0 to 28 weeks post‐partum.
ARVs negatively affected copper and zinc milk concentrations, but only at 2 weeks, whereas
LNS had no effect. Among all treatment groups, approximately 80–90% of copper and zinc and
<50% of iron concentrations met the current adequate intake for infants at 2 weeks and only
1–19% at 24 weeks. Pregnancy haemoglobin was negatively correlated with milk iron at 2 and
6 weeks (r = −.18, p < .02 for both). The associations of the milk minerals with each other were
the strongest correlations observed (r = .11–.47, p < .05 for all); none were found with infant bio-
markers. At 2 weeks, moderately anaemic women produced milk higher in iron when ferritin was
higher or TfR lower. At 6 weeks, higher maternal α‐1‐acid glycoprotein and C‐reactive protein
were associated with higher milk minerals in mildly anaemic women. Infant TfR was lower when
milk mineral concentrations were higher at 6 weeks and when mothers were moderately anaemic
during pregnancy. ARV affects copper and zinc milk concentrations in early lactation, and mater-
nal haemoglobin during pregnancy and lactation could influence the association between milk
minerals and maternal and infant iron status and biomarkers of inflammation.
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Key messages
• Maternal supplementation with lipid‐based nutrient
supplements during lactation had no effect on iron,
copper, and zinc concentrations in human milk.
• Maternal antiretroviral therapy negatively affected
copper and zinc concentrations in human milk in early
lactation.
• Milk mineral concentrations quickly decreased during
lactation with less than 50% of samples with adequate
iron concentrations at 2 weeks.
• The strongest correlations throughout lactation were
found among the milk minerals and milk fat.
• Maternal Hb during pregnancy or lactation could
influence the relationship between milk minerals and
maternal and infant biomarkers for inflammation and
iron stores.
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Human milk is thought to ensure a balanced and adequate supply
of nutrients to infants and is recommended by the World Health
Organization (WHO) as the sole food source for the first 6 months
of life (Brown, Engle‐Stone, Krebs, & Peerson, 2009; World Health
Organization, 2010). Maternal iron, copper, and zinc intake and
status are assumed to have no effect on human milk minerals
(Domellöf, Lönnerdal, Dewey, Cohen, & Hernell, 2004; Mello‐Neto
et al., 2013; Montalbetti, Dalghi, Albrecht, & Hediger, 2014; Moser
et al., 1988; Picciano, 2001; Vuori, Mäkinen, Kara, & Kuitunen,
1980); however, Krebs, Hambidge, Jacobs, and Rasbach (1985)
reported that milk zinc concentrations are affected by maternal
zinc intake within a physiological range and effects of low mater-
nal intakes are most apparent with prolonged lactation. Even
though the total concentration of iron, copper, and zinc in human
milk is low and decreases throughout lactation, their high bioavail-
ability is assumed to ensure adequate supply during the first
6 months (Dorea, 2000). Nevertheless, iron and zinc deficiencies
in the perinatal period remain a public health concern, particularly
in low‐income countries, including Malawi (Domellöf et al., 2004;
Gibson & Huddle, 1998; National Statistical Office & ICF, 2017),
causing symptoms such as diarrhoea, pneumonia, suboptimal
growth and development, normocytic hypochromic anaemia, or
even osteoporosis (Black et al., 2008; Dauncy, Shaw, & Urman,
1977).
In the context of maternal HIV infection, breastfeeding is
recommended for at least 12 months, with continued
breastfeeding up to 24 months, whereas maternal antiretroviral
(ARV) therapy is provided to reduce the risk of mother‐to‐child
HIV transmission (World Health Organization, 2016). However,
higher energy and nutrient requirements due to breastfeeding
and HIV infection might increase the risk of nutrient deficiencies
for mother and infant (de Pee & Semba, 2010; Kayira et al.,
2012). Our previous research has shown that ARVs negate the
positive effects of maternal lipid‐based nutrient supplement (LNS)
consumption during lactation on B‐vitamin concentrations in
maternal plasma and human milk (Allen et al., 2015; Flax et al.,
2015). Negative ARV effects have also been reported on vitamin
D and B12 status (Childs, Welz, Samarawickrama, & Post, 2012;
Paltiel, Falutz, Veilleux, Rosenblatt, & Gordon, 1995; Woods
et al., 2003). Thus, a potential impact of ARVs on iron, copper,
and zinc concentrations in milk is possible and remains to be
determined.
We analysed samples from a randomized controlled trial, in
which lactating women were assigned to either ARV or LNS, ARV
and LNS, or no intervention, to (a) examine the effects of ARV and
LNS on iron, copper, and zinc concentrations in milk; (b) compare
the concentration of each mineral analysed to the values that were
used to set the adequate intake (AI) for infants 0–6 months (Institute
of Medicine, 2001); (c) assess correlations among the milk nutrients
analysed (iron, copper, zinc, and fat); and (d) examine relationships
between milk minerals and maternal and infant characteristics and
mineral and inflammation status using maternal and infant
biomarkers.2 | METHODS AND MATERIALS
2.1 | Participants and sample collection
The participants of the Breastfeeding, Antiretrovirals, and Nutrition
(BAN) study included HIV‐infected women recruited 2004–2009 from
four antenatal clinics in Lilongwe, Malawi. Details of the recruitment
and study design have been previously described (Chasela et al.,
2010; Ferguson et al., 2009; Kayira et al., 2012; van der Horst et al.,
2009). Informed consent was obtained from all mothers. Based on
the WHO guidelines at the time of the study, participants were
encouraged to exclusively breastfeed for 24 weeks followed by rapid
weaning from 24 to 28 weeks.
At delivery, mothers and their infants were randomized to a two‐
arm (LNS, no‐LNS) by three‐arm (maternal ARV, infant ARV, or neither)
factorial design, which was condensed to four maternal intervention
groups (Figure S1). Infant ARV treatments were not considered as this
report focuses on breast milk minerals, and infant treatment would not
influence human milk status. Because the LNS purposely included pro-
vision of energy and macronutrients, and micronutrients, neither par-
ticipants nor physicians could be blinded to the study arm. Outcome
assessors and sample and data analysts were blinded to the treatment
allocation. The screening and enrollment process was conducted by
the study nurses; a data manager produced the random distribution.
The study pharmacist assigned the participants to the intervention
using sequentially numbered envelopes and handed out ARV and
LNS during the regular study visits at 0, 1, 2, 4, 6, 8, 12, 18, 21, 24,
and 28 weeks post‐partum. The women were instructed to consume
two sachets of the LNS per day produced by Nutriset, France, www.
nutriset.fr (Table S1). The LNS provided 0.3 mg copper, 19 mg zinc,
and 15 mg iron equivalent to 23, 158, and 168% of the U.S.–Canada
Recommended Dietary Allowances for copper, zinc, and iron, respec-
tively (Institute of Medicine, 2001). The maternal ARV regimen
consisted of zidovudine (300 mg) and lamivudine (150 mg; Combivir®,
GlaxoSmithKline) plus either nevirapine (until January 2005), nelfinavir
HAMPEL ET AL. 3 of 14bs_bs_banner(January 2005–February 2006) or lopinavir (200 mg) and ritonavir
(50 mg; Kaletra; Abbott; February 2006 until study completion).
Reports of maternal LNS consumption were obtained at 1, 4, 8, 12,
and 21 weeks. Maternal haemoglobin (Hb) was assessed at ≤30 weeks
gestation during the prenatal screening, and maternal and infant
venous blood was collected at birth, 2, 6, 12, 18, and 24 weeks for fur-
ther Hb measurements. Plasma for additional biomarker analysis was
separated from red blood cells within 60 min and stored at −70 °C in
1 ml aliquots. Ten millilitres of human milk was collected during the
regular study visits at 2 and 24 weeks (n = 366), or 6 and 24 weeks
(n = 169) when a 2‐week milk or infant plasma sample was insufficient
for micronutrient analysis. The milk was manually expressed by the
study participant yielding an opportunistic sample that was immedi-
ately frozen after collection. The number of participants with available
milk, maternal, and infant plasma samples predetermined the sample
size (n = 535). Participants were preferentially selected if they provided
anthropometry and dietary intake data. If the infants became HIV‐pos-
itive or were multiple births, they were excluded from the subset.
Details of the primary study0s sample size calculations have been pre-
viously described (van der Horst et al., 2009).
Samples were initially shipped on dry ice to the Centers for Dis-
ease Control and Prevention in Atlanta and stored at −80 °C until dis-
tribution to the USDA, ARS Western Human Nutrition Research
Center in Davis, California, for analysis.2.2 | Biochemical analyses
Iron, copper, and zinc were analysed in 500 μl of whole human milk.
One hundred fifty microlitres of the 1.00 ppm calibration standard in
nitric acid (HNO3, 3.2N, for trace analysis), 2.25 ml HNO3 (3.2N), and
100 μl peroxide (for trace analysis) were added to a final volume of
3.0 ml. Samples were mixed and microwaved for 15 min at 90 °C
(600 W, 5 min ramp from ambient temperature to 90 °C, temperature
controlled). After a 5‐min cooling step, the samples were centrifuged
for 10 min at 2,750 × g (4 °C) after which they were transferred into
the 8 ml polypropylene tubes (13 × 100 mm, Perfector Scientific, Fair
Lawn, NJ, USA) for analysis or capped and stored at 4 °C until analysis.
The laboratory internal control BLS (National Institute of Standards
and Technology standard reference material (SRM)1577c bovine liver,
NIST, Gaithersburg, MD) and the 0.2 ppm standard, analysed with each
sample set, revealed an inter‐assay variation of 1.5–7.0% and an intra‐
assay variation of 0.1–10.8% over a period of 6 weeks (n = 25). The
calibration curve for each mineral consisted of a blank and 10 standard
solutions in a linear range of 0.0125–2.000 ppm prepared in 3.2N
HNO3. Due to the difference in concentration of each analyte in
human milk, the actual standard concentrations used for each mineral
were as follows: Cu: 0.0125–1.000 ppm, Fe: 0.025–1.000 ppm, and
Zn: 0.0125–2.000 ppm. Mean recovery rates for copper, iron, and zinc
were 92.6 ± 5.7%, 89.4 ± 7.2%, and 94.7 ± 6.8%, respectively. The
analyses were conducted using a Varian Vista AX CCD Simultaneous
ICP‐AES (Folsom, CA, USA) operated by ICPExpert software. Samples
were digested using the CEM microwave accelerated reaction system
(MARS 5; Matthews, NC, USA). The milk fat was measured using the
Creamatocrit Plus (Medela, McHenry, IL, USA) according to themanufacturer0s protocol. The tube reader0s accuracy was validated
using the Medela control strip.
The inflammatory markers α‐1‐acid glycoprotein (AGP) and C‐
reactive protein (CRP) and soluble transferrin receptors (TfR) in mater-
nal and infant plasma were analysed by a COBAS® INTEGRA 400 plus
multianalyte analyser (Roche Diagnostics, Mannheim, Germany). Ferri-
tin concentrations were determined using IRMA Ferritin Coat‐a‐Count
radioimmunoassay (Siemens Health Care Diagnostics, Tarrytown, NY,
USA), and Hb was measured using the AcT or AcT 5‐part Differential
Analyser (Beckman Coulter, Fullerton, CA, USA).2.3 | Ethics
This research was approved by the Malawian National Health Science
Research Committee, the Institutional Review Boards at the University
of North Carolina at Chapel Hill, the U.S. Centers for Disease Control
and Prevention, and the University of California, Davis (Clinical Trials.
gov; NCT00164762). The trial was monitored for safety and efficacy
by the National Institute of Allergy and Infectious Diseases Vaccine
and Prevention Data and Safety Monitoring Board.2.4 | Statistical methods
Becausemilk sample collection started 2 to 6weeks after the LNS inter-
vention, no true baseline concentrations were available for statistical
analyses (Allen et al., 2015). A separate binary variable, hereafter
referred to FTP (first time point), was used to control for whether the
FTP of sample collection occurred at 2 (FTP2) or 6 weeks (FTP6). The
outcomes were concentrations of iron, copper, and zinc in human milk,
within the four defined groups (ARV, LNS, ARV/LNS, and control).
SAS® forWindows Release 9.4 (SAS Institute, Cary, NC, USA) was used
for all statistical analyses. Square root transformations were performed
on all outcome variables to normalize the distributions. The original
hypothesis focused on the effect of LNS supplementation on outcomes.
However, preliminary data revealed significant effects due to ARV for
some of the minerals, so the hypothesis was modified to include possi-
ble main effects and modifying effects of ARV. Mixed models repeated
measures analysis of variance was used to fit a four‐factor model, which
included LNS, ARV, and FTP as between‐subject main effects, time as a
within‐subject main effect, all two‐, three‐, and four‐factor interactions,
and a random effect of subject assuming an unstructured covariance
matrix. When there was no significant interaction between treatment
and FTP, treatment was assessed as a main effect only.
All analyses described in this paragraph were conducted using
pooled milk values for each mineral from all treatment groups. Iron,
copper, and zinc milk concentrations were significantly lower at
6 weeks than at 2 weeks; thus, to estimate the correlations of the
breast milk iron, copper, and zinc concentrations with maternal and
infant biomarkers and characteristics, we analysed the data separately
by FTP (2 or 6 weeks) subgroup. Pearson correlations procedure was
used. Concentrations of maternal ferritin, maternal CRP, maternal
TfR, infant ferritin, infant CRP, infant AGP, and maternal age were
log‐transformed; infant TfR and birthweight were square‐root trans-
formed, and maternal AGP, body mass index (BMI), and infant Hb were
inverted (1/x) to achieve normal distributions. Inverted variables were
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infant birth length were normally distributed and not transformed.
Spearman correlations were used to explore relationships of breast
milk iron, copper, and zinc concentrations with non‐normalized mater-
nal and infant characteristics including marital status, literacy, educa-
tion, parity, famine season (August to March), and infant sex. Linear
regression analysis was used to examine associations (a) between
maternal iron status (ferritin, TfR) and inflammation (AGP, CRP) bio-
markers on human milk iron, copper, and zinc at 2, 6, and 24 weeks,
stratified by anaemia status during pregnancy (non‐anaemic:
Hb ≥ 110 g/L, mildly anaemic: Hb 100–109 g/L, moderately anaemic:
Hb 70–99 g/L, and severely anaemic: Hb ≤ 70 g/L) and lactation
(non‐anaemic: Hb ≥ 120 g/L, mildly anaemic: Hb 110‐119 g/L, moder-
ately anaemic: Hb 80‐109 g/L, and severely anaemic: Hb ≤ 80 g/L;
World Health Organization, 2011) and (b) between maternal iron sta-
tus biomarkers (ferritin, TfR, Hb, and pregnancy Hb) on human milk
iron, copper, and zinc at 2, 6, and 24 weeks, stratified by inflammation
status (AGP > 1 g/L and CRP > 5 mg/L).
For all procedures, p values < .05 were considered to be statisti-
cally significant. Significant differences in the distribution of categori-
cal variables were examined using the chi‐square test. Significant
changes in milk adequacy (based on AI) over time (2, 6, and 24 weeks)
were tested using the GLIMMIX procedure.
The measured human milk iron, copper, and zinc concentrations at
each time point (TP), FTP of milk collection, and treatment group were
also compared to milk values from well‐nourished women used by the
Institute of Medicine to set AIs for infants from 0–6 months of age
(Institute of Medicine, 2001).3 | RESULTS
3.1 | Maternal characteristics at FTP
The characteristics of the participants were similar among treatment
groups at the FTP of human milk collection (Table 1). Significant differ-
ences were only observed for the CD4 counts with higher counts for
the groups that received ARV. The median BMI was within the normal
range and the overall compliance with supplementation and ARV treat-
ment was high. In the adherence reports collected over five follow‐up
visits, the mothers self‐reported that they took their prescribed ARV
treatment 89% of the time and LNS supplement 92% of the time.
The self‐reported frequency of exclusive breastfeeding was 96% at
21 weeks post‐partum (Chasela et al., 2010; Kayira et al., 2012).3.2 | Treatment effects and time interactions
The mixed model analysis revealed that the concentrations of the
three minerals changed over time (TP) and differed by FTP (p < .02
for all). For iron, no interactions by treatment (ARV and LNS) or with
treatment and TP and/or FTP were significant indicating that the
effects of ARV and LNS at 2, 6, and 24 weeks were not different from
each other (Table S2). Therefore, pooled data for all treatment groups
and all TPs combined were used for further statistical analyses involv-
ing iron. ARV by TP by FTP interactions were significant for copper
(p = .034), whereas ARV by FTP interactions were significant for zinc(p = .031). Thus, to evaluate the main effects, samples from 2, 6, and
24 weeks were analysed separately for copper and zinc.
The reduction in milk iron concentrations between 2, 6, and
24 weeks was independent of treatment. ARV by LNS interactions
were not significant for any of the minerals analysed nor were LNS
and ARV main effects significant for iron (Table 2). The mixed model
analysis for copper and zinc at 2, 6, and 24 weeks showed that ARV
treatment significantly and negatively affected milk copper and zinc
concentrations (p = .044 and p = .014) but only at the initial 2 weeksTP.3.3 | Comparison of milk iron, copper, and zinc
concentrations with values used to set the AI for
infants 0–6 months
At 2 weeks, 38–48% of all milk samples met the milk iron concentra-
tions assumed from reported data used to estimate the AI for infants
from 0 to 6 months (Table 3). Depending on treatment group, approx-
imately 89–94% and 78–88% of the samples had copper and zinc con-
centrations at 2 weeks that corresponded to AI values (Institute of
Medicine, 2001).
Lower breast milk iron, copper, and zinc concentrations were
observed at 6 weeks: 27–35% of the milk samples met the AI for iron
concentrations and 39–61% and 40–47% the AI for copper and zinc
concentrations.
At 24 weeks, only about 11–19% of all samples met the AI esti-
mates for iron. Copper and zinc concentrations were even lower; only
5–9% (copper) and 1–4% (zinc) of the samples met the AI concentra-
tions. Plotting the relative amount of samples that met the AI longitu-
dinally by FTP subgroup (2–24 and 6–24 weeks), copper and zinc
followed the same pattern of decrease, whereas the iron AI was met
by considerably fewer samples compared to the copper and zinc
already at 2 weeks, but then followed a slower rate of decrease
(Figure 1).3.4 | Correlations of maternal and infant biomarkers
and characteristics with breast milk minerals
Iron, 2 and 6 weeks: At 2 weeks, human milk iron concentrations were
significantly correlated with pregnancy Hb (r = −.18, p < .001) and par-
ity (r = −.11, p = .031) as well as with breast milk copper (r = .29,
p < .001), zinc (r = .11, p = .028), and fat (r = .11, p = .044; Figure 2).
At 6 weeks, breast milk iron was correlated with pregnancy Hb
(r = −.18, p = .019), maternal AGP (r = −.25, p = .001), and breast milk
copper (r = .47, p < .001) and fat (r = .24, p = .002).
Copper, 2 and 6 weeks: At 2 weeks, human milk copper concen-
trations were correlated with maternal AGP (r = .12, p = .021) and
CRP (r = −.19, p < .001) and milk iron, zinc (r = .36, p < .001), and fat
(r = .13, p = .01; Figure 2). At 6 weeks, milk copper was also correlated
with pregnancy Hb (r = −.15, p = .047), maternal AGP (r = −.15,
p = .049), and breast milk iron and zinc (r = .28, p < .001).
Zinc, 2 and 6 weeks: At 2 weeks, milk zinc concentrations were
significantly correlated only with milk iron and copper. At 6 weeks,
human milk zinc was correlated with maternal AGP (r = −.17, p = .03)
and breast milk copper.
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TABLE 3 Percentage [%] of milk samples from the subsample of the BAN study that meet the values used to set the adequate intake (AI) for each
mineral, by collection time and treatment group
Mineral AI Control LNS ARV ARV/LNS
[mg/L] [mg/L] [%] (n) [%] (n) [%] (n) [%] (n) p valueb
Iron
2 weeks 0.346 48 (57/118) 44 (61/140) 45 (24/53) 38 (21/55) 0.62
6 weeks 32 (19/59) 27 (12/45) 35 (11/31) 32 (11/34) 0.83
24 weeks 18 (31/177) 16 (30/185) 11 (9/85) 19 (15/80) 0.54
p valuea < 0.024
Copper
2 weeks 0.256 91 (107/118) 94 (132/140) 92 (49/53) 89 (49/55) 0.64
6 weeks 39 (23/59) 44 (20/45) 61 (19/31) 50 (17/34) 0.17
24 weeks 9 (15/177) 6 (11/185) 9 (8/85) 5 (4/80) 0.48
p value < 0.001
Zinc
2 weeks 2.564 88 (104/118) 88 (123/140) 81 (43/53) 78 (43/55) 0.21
6 weeks 44 (26/59) 40 (18/45) 45 (14/31) 47 (16/31) 0.92
24 weeks 3 (6/177) 1 (2/185) 4 (1/85) 1 (1/85) 0.34
p value < .001
Note. ARV = antiretrovirals; BAN = Breastfeeding, Antiretrovirals, and Nutrition; LNS = lipid‐based nutrient supplement; number of samples given in paren-
theses (numerator: n of samples that met AI, denominator: total n).
ap values for comparison of proportions of samples with adequate milk iron, copper, zinc concentrations over time (2, 6, 24 weeks; proc glimmix).
bp value for comparison of proportions of samples with adequate milk iron, copper, and zinc concentrations based on treatment (LNS, ARV, ARV/LNS, and
control; chi‐square test).
TABLE 2 Median concentrations and interquartile ranges (IQR) of iron, copper, and zinc and main effects of ARV and LNS of iron, copper, and zinc
at 2, 6, and 24 weeks in breast milk of HIV‐infected Malawian mothers assigned to one of the four treatment arms in the BAN study
Treatment Iron Copper Zinc
Week 2 6 24 2 6 24 2 6 24
Control n 118 59 177 118 59 177 118 59 177
mg/L Median 0.342 0.250 0.190 0.387 0.223 0.143 3.57 2.49 1.16
IQR 0.23–0.50 0.17–0.40 0.13–0.30 0.32–0.47 0.20–0.31 0.10–0.18 3.01–4.21 2.07–3.06 0.75–1.57
LNS n 140 45 185 140 45 185 140 45 185
mg/L Median 0.331 0.230 0.188 0.372 0.247 0.127 3.59 2.39 1.05
IQR 0.25–0.49 0.14–0.37 0.11–0.27 0.32–0.45 0.21–0.30 0.09–0.17 2.92–4.31 1.89–3.10 0.70–1.56
ARV n 53 31 85 53 31 85 53 31 85
mg/L Median 0.337 0.297 0.157 0.379 0.273 0.151 3.16 2.46 1.05
IQR 0.24–0.46 0.16–0.45 0.11–0.27 0.32–0.45 0.23–0.35 0.12–0.207 2.75–3.63 1.95–3.20 0.75–1.54
ARV/LNS n 55 34 90 55 34 90 55 34 90
mg/L Median 0.301 0.265 0.210 0.341 0.258 0.141 3.40 2.47 1.13
IQR 0.21–0.43 0.13–0.36 0.13–0.27 0.29–0.40 0.21–0.33 0.10–0.18 2.88–3.85 1.95–2.94 0.72–1.57
Treatment effectsa
LNS LS mean 0.516 0.615 0.504 0.362 1.87 1.53 1.04
No LNS LS mean 0.514 0.621 0.508 0.376 1.86 1.57 1.07
p value .86 .49 .80 .08 .74 .34 .14
ARV LS mean 0.505 0.603 0.519 0.378 1.82 1.55 1.06
No ARV LS mean 0.520 0.624 0.498 0.364 1.89 1.55 1.06
p value .23 .044 .16 .11 .014 .95 .95
Note. ARV = antiretrovirals; BAN, Breastfeeding, Antiretrovirals, and Nutrition; LNS, lipid‐based nutrient supplement; LS Mean = least‐square mean.
aTreatment effects (LNS–no LNS; ARV–no ARV) were tested by mixed model repeated measures analysis of variance. Treatment effects for iron are derived
from a pooled sample (2, 6, and 24 weeks combined).
6 of 14 HAMPEL ET AL.bs_bs_bannerIron, copper, and zinc, 24 weeks: At 24 weeks, neither iron nor
copper concentrations were correlated with any of the maternal or
infant biomarkers (Figure 2). Only zinc showed a correlation with
maternal BMI (r = .12, p = .006). Significant correlations remainedbetween the analysed human milk minerals and fat: Iron was correlated
with copper (r = .31, p < .001) and fat (r = .22, p < .001) and copper with
zinc (r = .11, p < .001) and fat (r = .21, p < .001); additionally, zinc was
correlated with fat (r = .13, p = .003).
FIGURE 1 Relative median decrease (%) in human milk iron, copper,
and zinc over time compared to AI (values pooled from all treatment
groups at each time point of sample collection: (a) FTP2 subgroup (2–
24 weeks; n = 366); (b) FTP6 subgroup (6–24 weeks; n = 169).
AI = adequate intake; FTP = first time point
FIGURE 2 Significant correlations between milk minerals and maternal
(Spearman correlations coefficient for the characteristics) are shown and le
Preg = pregnancy (during screening); Hb = haemoglobin; BM = breast milk
glycoprotein; CRP = C‐reactive protein; BMI = body mass index
HAMPEL ET AL. 7 of 14bs_bs_bannerNone of the infant biomarkers or characteristics were significantly
associated with human milk iron, copper, or zinc concentrations at any
TP.3.5 | Associations of human milk iron, copper, and
zinc with maternal and infant biomarkers, stratified by
maternal Hb (anaemia status) during pregnancy and
lactation
3.5.1 | Maternal biomarkers
2 weeks: When women were moderately anaemic post‐partum, higher
ferritin during lactation was associated with higher human milk iron
concentrations when compared to mildly anaemic (p = .017) and non‐
anaemic (p = .037, Figure 3) pregnant women, whereas higher TfR in
lactation was associated with lower milk iron compared to the non‐
anaemic group (p = .024). Additionally, higher maternal CRP during lac-
tation was associated with lower milk copper compared to that of non‐
anaemic women (p = .016). The degree of anaemia in pregnancy did
not affect the relationship of the maternal biomarkers to milk zinc con-
centrations (data not shown). When women were moderately anaemic
during pregnancy, higher TfR concentrations post‐partum were associ-
ated with lower milk iron concentrations compared to those of non‐
anaemic women (p = .030).
6 weeks: In women who were mildly anaemic during lactation,
higher CRP post‐partum was associated with higher milk iron
(p = .013) and copper (p = .036) compared to non‐anaemic women,
whereas higher AGP was associated with higher milk iron (p = .002)
and zinc (p = .002) concentrations. Higher AGP was associated withbiomarkers at 2, 6, and 24 weeks. Pearson0s correlation coefficients
vel of significance as: *p < .05; **p < .01; ***p < .001.
; Fe = iron; Cu = copper; Zn = zinc; Mat = maternal; AGP = α‐1‐acid
FIGURE 3 Associations of human milk iron, copper, and zinc with maternal biomarkers stratified by maternal haemoglobin status during pregnancy
and lactation (coefficients and SEs obtained from regression procedure displayed as bar graphs with error bars). p values for comparisons of
moderately or mildly anaemic to non‐anaemic group, and comparison of moderately to mildly anaemic group, using linear regression analysis.
Anaemia, state of anaemia—moderately, mildly, or non‐anaemic—based on maternal haemoglobin status at indicated week post‐partum (World
Health Organization, 2003). AnaemiaPreg, state of anaemia during pregnancy (moderately, mildly, or non‐anaemic based on maternal Hb during
pregnancy, World Health Organization, 2003). BM = breast milk; CRP = C‐reactive protein; AGP = α‐1‐acid glycoprotein; TfR = soluble transferrin
receptors; n = number of samples (moderately anaemic/mildly anaemic/non‐anaemic): 2 weeks anaemia: 41/49/276; 2 weeks anaemiaPreg: 91/
106/169; 6 weeks anaemia: 13/25/131; 6 weeks anaemiaPreg: 35/53/81; 24 weeks anaemia: 16/45/476; 24 weeks anaemiaPreg: 126/160/251;
separate models were used for each time point and first time point and anaemia status
8 of 14 HAMPEL ET AL.bs_bs_bannerlower copper concentrations when comparing moderately anaemic
post‐partum women to mildly anaemic women (p = .004), yet higher
AGP was associated with higher copper when comparing mildly anae-
mic to non‐anaemic post‐partum women (p = .005). When women
were moderately anaemic during pregnancy, higher post‐partum
AGP concentrations at 6 weeks were associated with higher milk iron
concentrations compared to concentrations in non‐anaemic women
(p = .027).
24 weeks: Higher maternal TfR concentrations at 24 weeks were
associated with lower milk iron values in moderately (p = .008) and
mildly (p = .009) anaemic women compared to non‐anaemic partici-
pants at 24 weeks.3.5.2 | Infant biomarkers
2 weeks: Higher milk copper was associated with lower AGP at
2 weeks among infants of mothers who were mildly anaemic during
lactation, compared to infants of mothers who were not anaemic,
(p = .037; Figure 4). For those infants whose mothers were moderately
anaemic during pregnancy, higher milk zinc was associated with higher
infant TfR concentrations compared to infants born to women who
were not anaemic during pregnancy (p = .037).
6 weeks: When the women had been mildly anaemic during
lactation, higher milk iron concentrations were associated withlower infant ferritin (p = .018) compared to infants born to non‐
anaemic women. When mothers were moderately anaemic during
pregnancy, higher milk iron, copper, and zinc concentrations were
associated with lower infant TfR compared to women whom were
not anaemic (piron = .004, pcopper = .016, pzinc = .018). When
women were mildly anaemic during pregnancy, higher milk iron
and copper were associated with lower infant AGP at 6 weeks
compared to non‐anaemic women during pregnancy (piron = .041,
pcopper = .043).
24 weeks: When mothers were moderately anaemic, increasing
copper in milk was associated with increasing infant CRP when com-
pared to mildly (p = .046) and non‐anaemic (p = .009) women.3.6 | Human milk iron, copper, and zinc
concentrations and inflammation
In the pooled samples set (n = 1,074), iron, copper, and zinc con-
centrations in the milk of HIV‐infected Malawian mothers were
significantly higher (p < .001 for all; Table 4) in women with evi-
dence of inflammation (AGP > 1 g/L, CRP > 5 mg/L). Moreover,
women with inflammation revealed higher milk iron concentrations
at 2 weeks when their pregnancy Hb status was lower, p = .015;
no inflammation: coeff. (std error): −0.012 (0.010), inflammation:
−0.050 (0.013), and showed higher milk zinc concentrations at
FIGURE 4 Associations of human milk iron, copper, and zinc with infant biomarkers stratified by maternal haemoglobin status during pregnancy
and lactation (coefficients and SEs obtained from regression procedure displayed as bar graphs with error bars). p values for comparisons of
moderately or mildly anaemic to non‐anaemic group, and comparison of moderately to mildly anaemic group, using linear regression analysis.
Anaemia, state of anaemia—moderately, mildly, or non‐anaemic—based on maternal haemoglobin status at indicated week post‐partum (World
Health Organization, 2003). AnaemiaPreg, state of anaemia during pregnancy (moderately, mildly, or non‐anaemic based on maternal Hb during
pregnancy, World Health Organization, 2003). BM = breast milk; CRP = C‐reactive protein; AGP = α‐1‐acid glycoprotein; TfR = soluble transferrin
receptors; n = number of samples (moderately anaemic/mildly anaemic/non‐anaemic): 2 weeks anaemia: 41/49/276; 2 weeks anaemiaPreg: 91/
106/169; 6 weeks anaemia: 13/25/131; 6 weeks anaemiaPreg: 35/53/81; 24 weeks anaemia: 16/45/476; 24 weeks anaemiaPreg: 126/160/251;
separate models were used for each time point and FTP and anaemia status
TABLE 4 Median concentrations and interquartile ranges (IQR) of the
pooled samples (all TP and FTP) of iron, copper, and zinc in breast milk
of HIV‐infected Malawian mothers in the BAN study based on
inflammation status
Mineral No inflammation Inflammation
n 835 239
Iron
Median, mg/L 0.224 0.325
IQR, mg/L 0.140–0.342 0.212–0.456
p valuea <.001
Copper
Median, mg/L 0.196 0.291
IQR, mg/L 0.129–0.319 0.192–0.375
p value <.001
Zinc
Median, mg/L 1.75 2.90
IQR, mg/L 0.988–2.93 1.69–3.74
p value <.001
Note. Inflammation defined as AGP > 1 g/L and CRP > 5 mg/L.
ap values obtained from general linear models.
HAMPEL ET AL. 9 of 14bs_bs_banner6 weeks when their pregnancy Hb status was higher, p = .020; no
inflammation: coeff. (std error): −0.032 (0.022), inflammation: 0.091
(0.047).4 | DISCUSSION
The recommendation to exclusively breastfeed for the first
6 months of life demands an understanding of how maternal micro-
nutrient supplementation and drugs, such as ARVs, affect human
milk nutrient concentrations. LNS are commonly used to treat
severe acute malnutrition in children; their effectiveness in improv-
ing birth and health outcomes in infants and children with moderate
malnutrition and their effectiveness in prevention of stunting has
also been under evaluation (Adu‐Afarwuah et al., 2015; Prado
et al., 2016; Phuka et al. 2009; Thakwalakwa et al., 2010). In the
BAN study, maternal LNS mitigated maternal weight loss even
when ARVs were given (Kayira et al., 2012) and increased human
milk B‐vitamin concentrations, whereas ARVs negatively affected
some B‐vitamins. When ARV and LNS were given, ARV diminished
the positive LNS effect (Allen et al., 2015). However, beneficial
effects of maternal supplementation or fortification on human milk
B‐vitamins have been also observed in other studies (Duggan et al.,
2014; Shahab‐Ferdows et al., 2015; Siddiqua et al., 2016; Whitfield
et al., 2016).4.1 | Treatment effects
Human milk iron, copper, and zinc concentrations are thought to be
unaffected by maternal supplementation (Domellöf et al., 2004;
10 of 14 HAMPEL ET AL.bs_bs_bannerMontalbetti et al., 2014; Moser et al., 1988; Picciano, 2001; Vuori
et al., 1980), which is consistent with our results. Maternal ARV treat-
ment, however, negatively affected milk copper and zinc concentra-
tions at 2 weeks, resulting in a 5–8% reduction of the median copper
and zinc concentration available to the infant. These reduced amounts
might not be significant to a healthy infant but could impact infants
exposed to nutritional deficiencies as they do not possess extensive
zinc or copper stores. Moreover, maternal ARV treatment in this study
was reflected in the milk, and lamivudine was found in infant plasma
(Corbett et al., 2014; Shapiro et al., 2005), observations particularly
important in light of the 2016 WHO guidelines that recommend ARV
provision to HIV‐infected mothers of HIV‐exposed infants. Certain
ARVs provided to the mother are transmissible through human milk,
which could impact the infants0 ability to fight a possible HIV infection
(Zeh et al., 2011). Thus, maternal ARVs are not only transferring to the
infant through human milk but also, in our study, affect the transfer of
zinc and copper during early lactation, and possibly other nutrients,
into milk and subsequently to the infant.
The milk mineral concentrations from these HIV‐infected mothers
were comparable to other reported values from healthy women in the
United States, Iran, and Brazil (Mahdavi, Nikniaz, & Gayemmagami,
2010; Mello‐Neto et al., 2013; Picciano & Guthrie, 1976). Thus, mater-
nal HIV status might not or only marginally affect milk mineral concen-
trations. However, another study conducted in the United States
revealed considerably higher mineral concentrations in milk from
apparently healthy mothers (Feeley, Eitenmiller, Jones, & Barnhart,
1983), whereas women in Vietnam produced milk with higher iron
and copper but lower zinc concentrations at 6 months post‐partum
(Nakamori et al., 2009).4.2 | Comparison of milk iron, copper, and zinc
concentrations with values used to set the AI for
infants 0–6 months
Despite the negative ARV effect on breast milk copper and zinc con-
centrations, 89–94% and 78–81%, respectively, of the milk samples
obtained at 2 weeks met the concentrations used to set the AI for
infants. When no ARVs were provided, 88% of the samples reached
adequate zinc concentrations at 2 weeks versus 78–81% when ARV
were taken, reiterating the already noted negative influence of ARV
on zinc levels in breast milk at early stages of lactation. Only 38–48%
of the iron concentrations at 2 weeks met AI values. However, the nat-
urally occurring decrease in concentrations during lactation (Brown
et al., 2009; Lönnerdal, Keen, & Hurley, 1981a; Silvestre et al., 2001)
was lower for iron than for copper and zinc, suggesting mineral‐spe-
cific kinetic rates of transport and secretion into milk. Iron, copper,
and zinc concentrations in milk are at their peak during the first few
days post‐partum and decrease as lactation progresses. However, the
concentrations of these trace minerals are remarkably stable at all lac-
tation stages as they are tightly regulated and maintained by the mam-
mary epithelial cells (Montalbetti et al., 2014).
Infants possess extensive iron stores in the liver that offset the
low milk levels and ensure adequate supply. Due to the extreme
changes in concentrations of minerals in milk within the first 6 months
post‐partum, a range of AI values would be more accurate forestimating adequate intake than the current single value approach;
the natural decrease in concentration will result in theoretically insuf-
ficient concentrations of these minerals in breast milk, even though
the infant may actually be adequately supplied. Moreover, the AI
values for these trace minerals are based on limited data (9–15 studies
with low numbers of participants; Institute of Medicine, 2001). Thus,
the concentrations of iron, copper, and zinc measured in our study can-
not be interpreted as insufficient based solely on the current AI esti-
mates. Longitudinal data from big data sets such as the BAN study
provide important additional information for the assessment of milk
mineral content.4.3 | Correlations of maternal and infant biomarkers
and characteristics with human milk minerals
In the BAN study, changes in maternal TfR and Hb were associated
with those observed in infant TfR and Hb (Widen et al., 2014). How-
ever, neither of these maternal or infant iron status biomarkers
showed a significant correlation with milk iron, copper, or zinc, indicat-
ing that the breast milk minerals are not the determining factor for
infant iron (TfR, ferritin, Hb) status during lactation. In fact, Mahdavi
et al. (2010) showed that milk iron, copper, and zinc concentrations
and the infant0s weight for age and height for age z‐score are not sig-
nificantly associated, and Murray, Murray, Murray, and Murray (1978)
reported no significant differences between milk iron and infant iron
status measures, showing the independence of infant outcomes from
human milk mineral concentrations.
Interestingly, we found that women with lower Hb during preg-
nancy (≤30 weeks gestation) produced milk with higher iron concen-
trations at both 2 and 6 weeks, whereas none of the post‐partum
maternal iron status biomarkers (Hb, ferritin, TfR) were associated with
milk minerals at these TPs, suggesting that maternal iron status during
pregnancy may affect milk iron concentrations during early stages of
lactation. Using BeWo cell layers as a model for placental iron transfer
in rats fed decreasing iron levels Gambling et al. (2001) found
increased mRNA and protein expression of TfR and of the divalent
metal transporter‐1 (DMT‐1). Recently, Jobarteh et al. (2017) con-
firmed an upregulation of mRNA of placental TfR1 in Gambian women
with low iron status; this increase might represent a mechanism to
ensure foetal requirements are met. Such alterations in iron metabo-
lism could also occur in the mammary epithelial cells that regulate min-
eral secretion into milk, which also involves TfR‐ and DMT1‐regulated
processes (Montalbetti et al., 2014). Given that this relationship was
observed in two independent groups and time of pregnancy during
screening did not affect Hb status (data not shown), this consistent sig-
nificant and negative association between pregnancy Hb and human
milk iron deserves further investigation. Parity and maternal BMI were
the only characteristics associated with breast milk minerals; whereas
parity and iron concentrations were correlated at 2 weeks, maternal
BMI and zinc concentrations were correlated at 24 weeks. These find-
ings indicate that higher parity could adversely affect iron, whereas
higher BMI might positively influence breast milk zinc concentration
during later stages of lactation.
The strongest correlations (all positive) were found among the
human milk minerals. All of them were also associated with the milk
HAMPEL ET AL. 11 of 14bs_bs_bannerfat, an observation previously described by Finley, Lönnerdal, Dewey,
and Grivetti (1985). Given that all three minerals are partly present in
the lipid fraction of the milk (Donangelo et al., 1989; Fransson &
Lönnerdal, 1980, 1982, 1984; Hirai et al., 1990; Linder et al., 1998;
Lönnerdal, Hoffman, & &Hurley L., 1982; Wooten, Shulze, Lancey,
Lietzow, & Linder, 1996), the correlation with milk fat is not unex-
pected. Copper and zinc are both bound to serum albumin, casein,
and citrate in milk (Lönnerdal et al., 1982); their positive association
suggests that the two minerals are not competing for the same binding
site but rather for the availability of additional binding capacity (Finley
et al., 1985; Lönnerdal, Keen, & Hurley, 1981b). Positive correlations
between milk iron and copper have also been reported by Feeley
et al. (1983), concluding that milk from mothers with high amounts
of iron may also be more likely to contain high concentrations of cop-
per. Given the intertwined relationships of mineral metabolism (Insti-
tute of Medicine, 2001), the close association of their concentrations
in milk is not surprising.4.4 | Associations of human milk iron, copper, and
zinc with maternal and infant biomarkers, stratified by
maternal Hb (anaemia status) during pregnancy and
post‐partum
Limited research has focused on the relationship of maternal and infant
iron status biomarkers with human milk mineral content. Kumar, Rai,
Basu, Dash, and Singh (2008) showed that severe maternal anaemia
adversely affected cord blood and human milk iron concentrations. In
our study, moderately anaemic women with higher ferritin also had a
higher concentration of iron in their milk compared to non‐anaemic
or only mildly anaemic women at 2 weeks, whereas lower TfR was
associated with higher milk iron content in moderately anaemic com-
pared to non‐anaemic women at 2 and 24 weeks. Although iron secre-
tion is tightly regulated and maintained by the mammary epithelial
cells, little is known about the molecular and cellular mechanisms reg-
ulating mineral concentrations in the milk (Montalbetti et al., 2014).
Thus, although milk iron concentrations are assumed to be indepen-
dent from maternal intake, our observations indicate the possibility
of a less understood yet complex relationship on the molecular and cel-
lular level between maternal iron status during pregnancy and the
amounts of iron in milk during early lactation.
At 6 weeks, mildly anaemic women with higher concentrations of
the inflammation biomarkers AGP and CRP also had higher concentra-
tions of iron, copper, and zinc in their milk than women with normal
Hb. Based on the categories of inflammation proposed by Thurnham
et al. (2008), about 23% of the mildly anaemic women at 6 weeks
showed early stages of infection or convalescence. After adjusting
for inflammation, the described relationships persisted, suggesting that
the association of maternal AGP/CRP and milk minerals in mildly anae-
mic women is not directly caused by inflammation (Table S5).
The degree of maternal anaemia during pregnancy or lactation
may also affect the relationship between breast milk minerals and
infant biomarkers. We found that infants from mildly anaemic mothers
at 2 weeks, who secrete more copper into milk, have lower AGP con-
centrations, an effect also found for breast milk iron and copper at
6 weeks for women who were mildly anaemic during pregnancy. InfantTfR also seemed to be affected by maternal Hb status and was lower
when breast milk iron, copper, and zinc were higher, but only when
comparing moderately anaemic to non‐anaemic mothers. To our
knowledge, no previous reports have investigated these associations.
These relationships between milk minerals and infant status may
be linked to maternal anaemia status. Alterations in maternal mineral
metabolism related to maternal iron status have been recently
described (Jobarteh et al., 2017); however, more research is necessary
to understand any influence of this effect on infant status.4.5 | Human milk iron, copper, and zinc
concentrations and inflammation
Information is sparse regarding the impact of inflammation on human
milk minerals. However, effects of inflammation on maternal status
may indirectly affect breast milk mineral concentrations. Inflammation
has been associated with reduced iron incorporation into haem, and
increased blood copper, and decreased zinc concentrations (Aggett &
Harries, 1979; Beshgetoor & Hambidge, 1998; Van den Broek &
Letsky, 2000). The leucocyte endogenous mediator is thought to be
involved by enhancing the hepatic uptake of zinc and iron and by syn-
thesis of acute phase proteins such as ceruloplasmin, a multi‐copper
ferrioxidase (Gambling, Andersen, & McArdle, 2008). Recent findings
describe an upregulation of placental iron and zinc transporters in
Gambian women with low iron and zinc status (Jobarteh et al., 2017),
proteins also located in the mammary gland (McCormick, Hennigar,
Kiselyov, & Kelleher, 2014; Montalbetti et al., 2014). These alterations
in mineral metabolism could extend into milk secretion, for example,
due to a signalling cascade. Our findings of higher milk iron, copper,
and zinc concentrations in women with inflammation indicate higher
influx of these minerals into milk when inflammation occurs. Moreover,
the inflammation‐related higher milk iron concentrations at 2 weeks
when the woman0s pregnancy Hb status was lower, and higher milk
zinc concentrations at 6 weeks when their pregnancy Hb status was
higher, support a potential upregulated iron and zinc secretion into
milk when women were subjected to health challenges such as low sta-
tus and inflammation. Interestingly, no such relationships were found
with Hb status during lactation, indicating that pregnancy Hb status
might have a stronger impact than Hb status during lactation. How-
ever, Van den Broek and Letsky (2000) also found an independent
effect of HIV‐infection on Hb concentrations that was not associated
with concurrent infection or dietary deficiencies. Thus, the extent of
the interrelationships of inflammation, pregnancy Hb, and milk mineral
concentrations has yet to be determined.4.6 | Limitations and conclusions
Despite the extensive number of milk samples analysed in the BAN
study, the samples collected are opportunistic and may not reflect a
24 h milk sample. Moreover, our initial samples were collected 2 and
6 weeks into the intervention, thus not reflecting a true baseline. The
low dose of copper in the LNS (only 23% of the Recommended Dietary
Allowance (RDA)) may also be insufficient to detect a difference in milk
copper concentrations. Exploring the data for associations based on
maternal Hb status resulted in a few subgroups with small sample sizes
12 of 14 HAMPEL ET AL.bs_bs_banner(e.g., n = 13 or 16, Figures 3 and 4; Tables S3 and S4), which may not be
generalizable to the larger population. However, unique characteristics
of the study include longitudinal collection of breast milk in a relatively
large sample of women, high adherence to recommendations to exclu-
sively breastfeed, and the randomized control design, which enabled
analysis of the effects of LNS and ARV, and their interactions, on milk
micronutrients. ARV affected milk copper and zinc concentrations and
was not offset by maternal supplementation during lactation. Even
though this negative effect appears to be limited and only at early lac-
tation, the extent of the impact on the infant has yet to be determined
as well as possible remedies. Although we found significant correla-
tions between maternal biomarkers and characteristics with milk min-
erals, those correlations were weak, and further studies are required
to gain better insight into the complex relationships between maternal
and infant biomarkers and breast milk mineral concentrations.
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